Cognitive and behavioral changes in rats under conditions of experimental ischemic stroke and their correction with mesenchymal stem cells and resveratrol
DOI:
https://doi.org/10.12775/JEHS.2024.57.018Keywords
acute cerebrovascular accident, mesenchymal stem cells, resveratrol, cognitive impairment, pathogenesis, experiment, neuroprotectionAbstract
The article presents the results of studying cognitive and behavioral impairments in rats under conditions of experimental acute cerebrovascular accident and of evaluating the effectiveness of its correction with mesenchymal stem cells and resveratrol. On the first day after modeling acute cerebrovascular accident, a pronounced neurological deficit was observed, accompanied by an increase in McGraw Stroke Index values (p<0.05) and a significant reduction in locomotor and exploratory activity. A marked deterioration in cognitive functions was recorded, manifested by an increase in the diving latency in the extrapolation release test (p<0.05). On day 14, a partial restoration of functions was observed; however, the impairments remained statistically significant. The administration of mesenchymal stem cells contributed to a moderate improvement in behavioral parameters, whereas combined therapy provided a more pronounced effect, which was reflected by an increase in the number of crossed squares (p<0.05), an increase in the number of explored holes (p<0.05), and a reduction in diving latency (p<0.05) compared to untreated animals.
References
1. Saini V, Guada L, Yavagal DR. Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology. 2021;97(2 Suppl):6–16. doi: 10.1212/WNL.0000000000012781.
2. Muratova T, Khramtsov D, Stoyanov A, Vorokhta Y. Clinical epidemiology of ischemic stroke: global trends and regional differences. Georgian Med News. 2020;299:83–6. PMID: 32242851.
3. Singh A, Kukreti R, Saso L, Kukreti S. Oxidative stress: a key modulator in neurodegenerative diseases. Molecules. 2019;24(8):1583. doi: 10.3390/molecules24081583.
4. Moñivas Gallego E, Zurita Castillo M. Mesenchymal stem cell therapy in ischemic stroke trials: a systematic review. Regen Ther. 2024;27:301–6. doi: 10.1016/j.reth.2024.03.026.
5. Shannon GS, Rinendyaputri R, Sunarno S, Malik A. Effects of stem cell therapy on preclinical stroke. Open Vet J. 2025;15(2):601–18. doi: 10.5455/OVJ.2025.v15.i2.9.
6. Canazza A, Minati L, Boffano C, et al. Experimental models of brain ischemia: a review of techniques, magnetic resonance imaging, and investigational cell-based therapies. Front Neurol. 2014;5:19. doi: 10.3389/fneur.2014.00019.
7. Liang Y, Chen J, Chen Y, Tong Y, Li L, Xu Y, Wu S. Advances in the detection of biomarkers for ischemic stroke. Front Neurol. 2025 Feb 24;16:1488726. doi: 10.3389/fneur.2025.1488726.
8. Mamedaliyeva Sevyndzh, Seleznova Sofiia, Mamedaliyev Novruz, Badiuk Nataliia, Gruzevskiy Alexander. Functional condition of platelets on the background of standard pharmaceutical treatment among patients with ischemic stroke / PharmacologyOnLine; Archives - 2021 - vol. 3 –1198-1205.
9. Maida CD, Norrito RL, Daidone M, et al. Neuroinflammatory mechanisms in ischemic stroke: focus on cardioembolic stroke, background, and therapeutic approaches. Int J Mol Sci. 2020;21(18):6454. doi: 10.3390/ijms21186454.
10. Szydlak R. Mesenchymal stem cells in ischemic tissue regeneration. World J Stem Cells. 2023;15(2):16–30. doi: 10.4252/wjsc.v15.i2.16.
11. Reznikov O. G., Solovyov A. I., Stefanov O. V. Biotic examination of preclinical and other scientific studies performed on animals: method. recommendations Herald of pharmacology and pharmacy. 2006;7:47–61.
12. Yang QQ, Zhou JW. Neuroinflammation in the central nervous system: symphony of glial cells. Glia. 2019;67(6):1017–35. doi: 10.1002/glia.23571.
13. Zhou L, Liang J, Xiong T. Research progress of mesenchymal stem cell-derived exosomes on inflammatory response after ischemic stroke. J Zhejiang Univ Med Sci. 2022;51(4):500–6. doi: 10.3724/zdxbyxb-2022-0077.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Yu. Khomut, I. Savytskyi, M. Ostapets

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 1
Number of citations: 0